PHARMA INTERNATIONAL has the capacity and licences required to import and distribute a complete range of pharmaceutical specialities and sanitary products.
Pharma International, collaborator of Rare Disease Day
Rare diseases are defined as being those that affect less than 5 per 10,000 of the population. The World Health Organisation estimates that there are nearly 7,000 rare diseases, affecting 7% of the world’s population.
In Spain, over 3 million people suffer from rare diseases.
We obtain medicines that can be used to treat the following rare diseases, among others:
Leishmaniasis
Sickle cell disease
Lennox-Gastaut’s syndrome
West syndrome
Sjögren’s syndrome
Primary hypercholesterolemia
Brugada Syndrome
We obtain medicines that can be used to treat the following oncological diseases, among others:
Primary peritoneal carcinoma
Malign tumour of the Fallopian tubes
Cancer of the ovary
Cancer of the pancreas, pancreatic neuroendocrine tumour
Brain tumours, Gliomas
Hodgkin’s lymphoma
Chronic myelogenous leukaemia
Neuroblastomas
Congenital or acquired generalised lipodystrophy
Malaria
Cerebral malaria
Plasmodium malariae
Infection by Plasmodium falciparum
Diphtheria
Tuberculosis
Invasive mycoses
Parkinson’s disease
Ulcerative colitis
Atypical pneumonia
Thyroiditis
Osteoarthritis
Antidotes
Vitamin deficiencies
Metabolic disorder
Antipsychotics
Would you like to collaborate in covering a higher number of treatments and reach more and new customers?
Business Area
info@pharmaintl.net
+34 915 635 856
Farmacovigilance
farmacovigilancia@pharmaintl.net
+34 915 635 856 (ext. 2005)
+34 634 941 272
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.